KR20060109492A - 염기성 의약 물질의 발포성 제제 - Google Patents

염기성 의약 물질의 발포성 제제 Download PDF

Info

Publication number
KR20060109492A
KR20060109492A KR1020067011963A KR20067011963A KR20060109492A KR 20060109492 A KR20060109492 A KR 20060109492A KR 1020067011963 A KR1020067011963 A KR 1020067011963A KR 20067011963 A KR20067011963 A KR 20067011963A KR 20060109492 A KR20060109492 A KR 20060109492A
Authority
KR
South Korea
Prior art keywords
acid
foamable
effervescent
pseudoephedrine
present
Prior art date
Application number
KR1020067011963A
Other languages
English (en)
Korean (ko)
Inventor
볼프강 빌
아이렌 루스
랄프 뷜레스바흐
디테르 렌
Original Assignee
바이엘 헬스케어 아게
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 바이엘 헬스케어 아게 filed Critical 바이엘 헬스케어 아게
Publication of KR20060109492A publication Critical patent/KR20060109492A/ko

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0002—Galenical forms characterised by the drug release technique; Application systems commanded by energy
    • A61K9/0007—Effervescent
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A61K31/137—Arylalkylamines, e.g. amphetamine, epinephrine, salbutamol, ephedrine or methadone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
    • A61K31/167—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide having the nitrogen of a carboxamide group directly attached to the aromatic ring, e.g. lidocaine, paracetamol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pain & Pain Management (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Emergency Medicine (AREA)
  • Biomedical Technology (AREA)
  • Urology & Nephrology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Cosmetics (AREA)
KR1020067011963A 2003-12-19 2004-12-07 염기성 의약 물질의 발포성 제제 KR20060109492A (ko)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE10359790.5 2003-12-19
DE10359790A DE10359790A1 (de) 2003-12-19 2003-12-19 Brausezubereitung einer basischen arzneilich wirksamen Substanz

Publications (1)

Publication Number Publication Date
KR20060109492A true KR20060109492A (ko) 2006-10-20

Family

ID=34683574

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1020067011963A KR20060109492A (ko) 2003-12-19 2004-12-07 염기성 의약 물질의 발포성 제제

Country Status (16)

Country Link
EP (1) EP1696874A1 (es)
JP (1) JP2007515418A (es)
KR (1) KR20060109492A (es)
CN (1) CN1893920A (es)
AR (1) AR046955A1 (es)
AU (1) AU2004308590A1 (es)
BR (1) BRPI0417796A (es)
CA (1) CA2550342A1 (es)
DE (1) DE10359790A1 (es)
EC (1) ECSP066649A (es)
IL (1) IL176356A0 (es)
MA (1) MA28276A1 (es)
MX (1) MXPA06006658A (es)
NO (1) NO20063327L (es)
WO (1) WO2005063199A1 (es)
ZA (1) ZA200604946B (es)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9078824B2 (en) 2007-09-24 2015-07-14 The Procter & Gamble Company Composition and method of stabilized sensitive ingredient
WO2010056216A1 (en) * 2008-11-11 2010-05-20 Berko Ilac Ve Kimya San.A.S. Pharmaceutical composition comprising ibuprofen, pseudoephedrine and chlorpheniramine
CN102438598B (zh) * 2009-05-27 2015-06-10 株式会社茶山医化 含有泡腾层的多层片
WO2013109224A1 (en) * 2012-01-18 2013-07-25 Mahmut Bilgic Pharmaceutical compositions comprising diclofenac
CN104622831B (zh) * 2013-11-06 2018-06-22 江苏豪森药业集团有限公司 一种口服片剂及其制备方法
CN107951034B (zh) * 2017-12-01 2021-03-23 郑州拓洋生物工程有限公司 维生素泡腾制剂及其制备方法

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4613497A (en) * 1984-02-29 1986-09-23 Health Products Development, Inc. Dry, water-foamable pharmaceutical compositions
CA2021548A1 (en) * 1989-09-01 1991-03-02 Ronald Nash Duvall Effervescent cold or sinus allergy medicine composition having reduced sodium content
CA2084028A1 (en) * 1991-11-27 1993-05-28 Harish B. Pandya Hot flu composition
AU7407194A (en) * 1993-08-03 1995-02-28 Warner-Lambert Company Pleasant tasting effervescent cold/allergy medications
JP2000063269A (ja) * 1998-08-20 2000-02-29 Taiho Yakuhin Kogyo Kk 固形製剤

Also Published As

Publication number Publication date
JP2007515418A (ja) 2007-06-14
AU2004308590A1 (en) 2005-07-14
CN1893920A (zh) 2007-01-10
CA2550342A1 (en) 2005-07-14
EP1696874A1 (de) 2006-09-06
NO20063327L (no) 2006-07-18
BRPI0417796A (pt) 2007-03-20
AR046955A1 (es) 2006-01-04
ECSP066649A (es) 2006-10-25
MXPA06006658A (es) 2006-08-31
DE10359790A1 (de) 2005-07-21
MA28276A1 (fr) 2006-11-01
ZA200604946B (en) 2007-09-26
IL176356A0 (en) 2006-10-05
WO2005063199A1 (de) 2005-07-14

Similar Documents

Publication Publication Date Title
KR940011246B1 (ko) 로라타딘, 이부프로펜 및 슈도에페드린을 함유하는 약제학적 조성물
ES2378255T3 (es) Titulación de tapentadol
US20080176955A1 (en) Combined administration of benzonatate and guaifenesin
US9265720B2 (en) Pharmaceutical formulations useful in the treatment of insomnia
JPWO2009102038A1 (ja) 口腔内崩壊錠
ZA200604946B (en) Effervescent preparation of a basic medicinal substance
JP7243876B2 (ja) 固形製剤
US20030039687A1 (en) Taste masking composition
US20070048375A1 (en) Effervescent preparation of a basic medicinally active substance
EP2802311B1 (en) Sublingual pharmaceutical composition containing an antihistamine agent and method for the preparation thereof
EP2243468A1 (en) Orally Disintegrating Dimebolin Compositions
EP2549983B1 (en) Novel composition for treatment of essential thrombocythemia
US20240009145A1 (en) Compositions of aspirin and ketamine
EP2848260B1 (en) Novel formulations of thiocolchicoside
EP2848259B1 (en) Sustained release pharmaceutical formulations of Thiocolchicoside
US20190209551A1 (en) Oral dosage forms for oxygen-containing active agents and oxyl-containing polymer
WO2002092058A1 (fr) Preparation solide se desintegrant rapidement

Legal Events

Date Code Title Description
N231 Notification of change of applicant
WITN Application deemed withdrawn, e.g. because no request for examination was filed or no examination fee was paid